摘要:
The present invention relates to novel retinoid-related orphan receptor gamma (RORy) modulators and their use in the treatment of diseases mediated by RORy.
摘要:
The present invention relates to novel retinoid-related orphan receptor gamma (RORy) modulators and their use in the treatment of diseases mediated by RORy.
摘要:
The present invention relates to cyclic guanidines, compositions containing such compounds and methods of treatment. The compounds are glucagon receptor antagonists and thus are useful for treating, preventing or delaying the onset of type 2 diabetes mellitus.
摘要:
The present invention relates to novel retinoid-reiated orphan receptor gamma (ROR y ) modulators and their use in the treatment of diseases mediated by ROR y .
摘要:
The present invention relates to novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORy.
摘要:
The present invention encompasses compounds of Formula I: as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating dyslipidemias. Pharmaceutical compositions and methods of use are also included.
摘要:
The present invention relates to no vel retinoid-related orphan receptor gamma (RQRy) modulators and their use in the treatment of diseases mediated by RORy.
摘要:
Disclosed are compounds having formula I, wherein X 1 , X 2 , X 3 , R 1 , R 2 , R 3 , R 4 , R 5 , Y, A, Z, L, m and n are as defined herein, and methods of making and using the same.